2026 BioInnovate Conference

Join the 2026 BioInnovate Conference, a curated forum connecting life sciences investors and industry leaders with promising spinouts from Weill Cornell Medicine, Cornell University, and Cornell Tech.

This event brings together academic inventors, early-stage investors, industry leaders, and startup executives to spark new connections, explore partnerships, and advance translational innovation. This year’s audience includes 40+ specialist biomedical investors and industry representatives.

Featured guests include:

• Michael Foley, PhD, CEO & Co-Founder, Excelsior Sciences
• Adam Volini, Executive Director & VP, Life Sciences & Strategic Partnerships, NYS Empire State Development
• Henry Wei, MD ’02, Head of Development Innovation, Regeneron

Startup pitches from:

• Astoria Biologica – first-in-class multiple sclerosis therapeutic
• NeuroTwain – digital clinical decision support tool for neurological diseases

The program will also include the announcement of the Resnick Prize for Excellence in Entrepreneurship and additional awards.

Over the years, BioInnovate has catalyzed venture financings, industry partnerships, and leadership team formation for emerging companies across the Cornell innovation ecosystem.

If you are in NYC, join us at Uris Auditorium on the Weill Cornell campus starting at noon. In-person registration here.

If you are in Ithaca or anywhere else, join us online from 3-6 PM (ET). Virtual registration here.